A Careful, Honest Comparison
Arthrosamid® vs
Knee Replacement
Arthrosamid® is not a substitute for knee replacement where replacement is clinically appropriate. It may be considered as non-surgical symptom management, but it has not been proved to delay replacement. Here is the decision the two options actually answer.
Reviewed byProfessor Paul YF Lee MBBch, FRCS (Tr & Orth), PhDCartilage and joint preservation expertiseQuick Answer
Arthrosamid® is not a substitute for knee replacement where replacement is clinically appropriate. Arthrosamid may be considered for symptom management in an appropriately selected adult, but it has not been proved to delay or prevent knee replacement. Advanced disease, deformity, instability or major functional loss may make replacement assessment the more appropriate route. The decision needs examination and imaging review.
The Headline Difference
Arthrosamid® vs Knee Replacement — the key difference
Knee replacement removes and replaces the joint surface — it is a major operation for end-stage arthritis with a strong evidence base. Arthrosamid® is a non-surgical injectable cushion that treats symptoms without altering the underlying joint. Where the joint and clinical picture make a non-surgical option reasonable, Arthrosamid may be discussed for symptoms; where the disease is end-stage, replacement may be the more appropriate and predictable route.
Mechanism of Action
How each treatment works
Arthrosamid® is a polyacrylamide hydrogel injected into the knee joint under ultrasound guidance. The gel integrates into the synovial membrane and is intended to remain in the joint. It is not regenerative.
It works mechanically by cushioning and lubricating the joint. It does not regenerate cartilage, does not reverse arthritis and does not alter the joint surface.
Total or partial knee replacement is a definitive surgical procedure in which the worn joint surfaces are removed and replaced with metal and polyethylene implants. The underlying arthritic surface is no longer present.
Modern knee replacement has a mature evidence base. Outcomes and risks vary, so an individual surgical consultation is needed rather than a promise of pain relief or longevity.
How Long Results May Last
Duration and number of injections
Observed to 24 months
Long-term surgical implant
Direct comparison of duration is misleading: Arthrosamid® treats symptoms in a joint that still has its own surface; replacement is a definitive operation that replaces the surface. They sit at different points on the treatment ladder.
Treatment Course
Number of injections
One injection is the standard treatment course in suitable patients. A further Arthrosamid® treatment may be considered at a future date if symptoms recur and the joint is still suitable.
Knee replacement is performed as one operation, but some implants later need revision. Longevity and revision risk depend on patient, implant, surgery, activity and follow-up.
Safety and Infection
Safety considerations
These are very different procedures with very different risk profiles. Arthrosamid® is an outpatient injection; a serious potential risk is joint infection. Knee replacement is major surgery with the risks inherent in any joint replacement — infection, venous thromboembolism, anaesthetic complications, and a rehabilitation period of weeks to months.
Arthrosamid® at London Cartilage Clinic uses routine IV antibiotic cover and ultrasound guidance. Knee replacement is delivered through hospital admission with the standard peri-operative care that surgery requires. See Arthrosamid® infection risk and prevention for the injection-specific protocol.
Patient Selection
Who each treatment may suit
Knee replacement is the right answer for end-stage osteoarthritis — bone-on-bone change, severe deformity, persistent symptoms despite conservative measures, and a clinical and imaging picture that supports it. We will say so honestly when this is the case.
Arthrosamid may be discussed for symptom management where a non-surgical option is reasonable, expectations are realistic and the safety protocol is acceptable. It is not proved to delay replacement and is not a substitute where surgery is clinically appropriate. See who is suitable for Arthrosamid?.
Cost and Value
What each treatment costs
At London Cartilage Clinic, Arthrosamid® costs from £3,000 for one box, inclusive of consultation, ultrasound, the product, the fifteen-step injection protocol and the six-week follow-up. See the Arthrosamid® cost guide.
Knee replacement costs and NHS access depend on provider, pathway and clinical eligibility. Obtain a current written quote or NHS pathway information rather than relying on a generic web price. The more important comparison is clinical: the treatments answer different needs.
Our Honest Take
When we may recommend each
You have established knee osteoarthritis with mild-to-moderate cartilage wear.
You want to discuss non-surgical symptom management with realistic expectations and willingness to accept the product-specific safety protocol.
Surgery has been suggested but you want to explore a non-surgical option first, and the imaging supports a non-surgical attempt being reasonable.
End-stage bone-on-bone osteoarthritis with persistent symptoms despite conservative care.
Significant deformity, instability or mechanical failure of the joint that an injection cannot address.
A clinical and imaging picture that points clearly to definitive surgery as the better answer.
When Each Is The Wrong Answer
When we would not recommend each
End-stage bone-on-bone arthritis where Arthrosamid® is unlikely to deliver meaningful benefit and replacement is the appropriate path.
Patients expecting Arthrosamid® to prevent knee replacement — that is not what the treatment can promise.
Active infection or unwillingness to accept the conservative safety protocol.
Mild-to-moderate osteoarthritis where conservative measures and a non-surgical injection have not yet been tried.
Significant comorbidity that makes major surgery a poor risk-benefit choice, where a less invasive option remains reasonable.
Patients whose current symptoms, imaging or health make further non-surgical management a reasonable discussion before committing to surgery.
The Bottom Line
In summary
Arthrosamid® and knee replacement sit at different points on the treatment ladder for knee osteoarthritis. Arthrosamid has not been proved to delay or prevent knee replacement, and it is not a substitute where replacement is clinically appropriate. Where non-surgical symptom management remains reasonable, Arthrosamid may be discussed. Where the disease is end-stage, replacement is usually the right answer. We will tell you honestly which one fits your case.
Arthrosamid® vs Knee Replacement
Frequently asked questions
Can Arthrosamid® help me avoid a knee replacement?
Arthrosamid has not been proved to delay or prevent knee replacement. It may be discussed as symptom management where non-surgical care remains reasonable, but it is not a substitute where replacement is clinically appropriate. The decision depends on symptoms, examination, imaging, function and goals.
Has Arthrosamid® been proved to delay knee replacement surgery?
No. The observational cohort reports group-level symptom outcomes through 24 months, but it has no randomised control group and was not designed to prove that replacement was delayed. Symptom change should not be converted into a surgery-delay claim.
Will Arthrosamid® make a future knee replacement more difficult?
Evidence is not sufficient to promise that a future operation will be unaffected. Tell any future surgeon about the product, injection date, response and any complication. A surgical team can then plan using the complete clinical record.
I have been told I need a knee replacement. Should I try Arthrosamid® first?
That needs individual assessment. Where non-surgical symptom management remains reasonable, Arthrosamid may be one option to discuss. Where the clinical and imaging picture supports replacement, an injection should not be presented as a substitute or a proved way to delay surgery.
Does Arthrosamid® regenerate cartilage or reverse arthritis?
No. Arthrosamid® is a non-absorbable hydrogel, not a regenerative treatment or cure. It does not regenerate cartilage or reverse the underlying arthritis. It manages symptoms while the underlying disease continues to be what it is. See the Arthrosamid® clinical evidence page.
Is knee replacement available on the NHS?
Yes, knee replacement is a routine NHS procedure for clinically appropriate cases, though waiting times vary. Arthrosamid® is not routinely funded by the NHS. See the Arthrosamid® funding and insurance page for the private-pay context.
Book an Arthrosamid® Assessment – London
Long-lasting relief starts with the right decision — not just an injection.